Health Transformation Through Prevention Requires Progress Metrics for Value Creation

preprint OA: closed
Full text JSON View at publisher

Abstract

The healthcare system faces significant challenges rooted in its fee-for-service model, which incentivizes interventions for the sick rather than prioritizing preventive measures, predictive health assessments, and early detection. Resistance to systemic reform results from the complex agendas of stakeholders, including clinicians, hospitals, insurers, policymakers, and technology providers. Patients, the core stakeholders, are rarely involved in shaping their health futures, however. Transitioning to a prevention-based model demands systemic change, emphasizing early stakeholder engagement, evidence-based solutions, training, and fostering innovation. Digital transformation and value-based care are essential to overcoming the "healthcare innovator's dilemma,” but they also require new business models, initial funding, and progress/value metrics to be accepted and adopted. The article discusses that while a health delivery transformation and disruption are needed, a business model for prevention will need to be developed and established in parallel. Investments in preventive technologies promise long-term cost reductions and improved health outcomes; they also require substantial upfront funding, which is unlikely to be provided through private investments without a future business model. To convince individuals and other stakeholders to spend more personal money, the value must be demonstrated and respective metrics developed. The article will also talk about the value of prevention for lower-income health environments and present opportunities in the context of reverse innovation.
Full text 621 characters · extracted from oa-doi-fallback · click to expand
There is a newer version available for this {{ publicationType }}. View latest version {{ publication.field_name }} {{ publication.subfield_name }} Copyright: © {{ publicationYear }} {{ publication.presentation_authors[0].full_name + (publication.presentation_authors.length > 1 ? ' et al' : '') }}. This is an open access publication distributed under the terms of the CC BY 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Check the {{ publicationType | capitalize }} Source for copyright and license information. Listen on

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00